TG Therapeutics TGTX Amortization Of Leasehold Interest
Amortization Of Leasehold Interest at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept tgtx:AmortizationOfLeaseholdInterest.
The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about TG Therapeutics's amortization of leasehold interest.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TG Therapeutics's amortization of leasehold interest?
- TG Therapeutics (TGTX) reported amortization of leasehold interest of $48K in Q1 2026.
- How has TG Therapeutics's amortization of leasehold interest changed year-over-year?
- TG Therapeutics's amortization of leasehold interest decreased by 0.0% year-over-year, from $48K to $48K.
- What is the long-term trend for TG Therapeutics's amortization of leasehold interest?
- Over 4 years (2021 to 2025), TG Therapeutics's amortization of leasehold interest has grown at a -3.3% compound annual growth rate (CAGR), from $212K to $185K.
- What does amortization of leasehold interest mean?
- This reflects the non-cash amortization of costs associated with improvements made to leased properties or the value of leasehold interests. It is treated as an operating expense that is added back to cash flow as it does not involve a current cash outlay.